Table 1 Comparison of clinical and echocardiographic characteristics between patients with EAT thickness ≦5 mm and >5 mm.
Characteristics | EAT thickness ≦5 mm (n = 124) | EAT thickness > 5 mm (n = 65) | P value | All patients (n = 189) |
---|---|---|---|---|
Age (year) | 59 ± 12 | 65 ± 10 | <0.001 | 61 ± 12 |
Male sex (%) | 61 | 42 | 0.013 | 54 |
Diabetes mellitus (%) | 48 | 46 | 0.852 | 47 |
Hypertension (%) | 53 | 51 | 0.748 | 52 |
Smoking (%) | 12 | 19 | 0.235 | 14 |
CAD (%) | 11 | 9 | 0.786 | 10 |
Stroke (%) | 8 | 12 | 0.345 | 10 |
CHF (%) | 25 | 31 | 0.396 | 27 |
SBP (mmHg) | 157 ± 28 | 149 ± 25 | 0.073 | 155 ± 27 |
DBP (mmHg) | 84 ± 16 | 77 ± 13 | 0.009 | 82 ± 15 |
BMI (kg/m2) | 23.4 ± 3.9 | 24.2 ± 3.8 | 0.178 | 23.7 ± 3.8 |
Albumin (g/dl) | 3.9 ± 0.3 | 3.8 ± 0.4 | 0.117 | 3.9 ± 0.3 |
Hb (g/dl) | 10.6 ± 1.3 | 10.3 ± 1.2 | 0.122 | 10.5 ± 1.2 |
Total cholesterol (mg/dl) | 175 ± 39 | 181 ± 43 | 0.374 | 177 ± 40 |
Triglyceride (mg/dl) | 170 ± 134 | 162 ± 104 | 0.670 | 167 ± 123 |
Medications | ||||
ACEI and/or ARB use (%) | 23 | 25 | 0.753 | 23 |
β-blocker use (%) | 21 | 22 | 0.927 | 21 |
CCB use (%) | 25 | 26 | 0.863 | 25 |
Echocardiographic data | ||||
LAVI (ml/m2) | 33 ± 12 | 35 ± 12 | 0.291 | 34 ± 12 |
LVMI (g/m2) | 138 ± 44 | 135 ± 39 | 0.617 | 136 ± 42 |
LVEF (%) | 62 ± 8 | 62 ± 7 | 0.935 | 62 ± 8 |
E (cm/s) | 83 ± 26 | 85 ± 38 | 0.670 | 83 ± 30 |
E’ (cm/s) | 7.0 ± 2.4 | 6.3 ± 2.2 | 0.083 | 6.7 ± 2.3 |
E/E’ | 13.5 ± 7.3 | 15.3 ± 9.3 | 0.163 | 14.0 ± 8.0 |
EAT thickness (mm) | 4.0 ± 1.0 | 7.0 ± 1.2 | <0.001 | 5.0 ± 1.8 |